Bleomycin Alternatives Compared
| Bleomycin | Nivolumab | Dacarbazine |
|
|---|
| Bleomycin | Nivolumab | Dacarbazine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hodgkin's Lymphoma, Testicular Cancer, Non-Hodgkin's Lymphoma, Squamous Cell Carcinoma. May also be prescribed off label for Malignant Pleural Effusion. |
Prescription only
Prescribed for Esophageal Carcinoma, Head and Neck Cancer, Colorectal Cancer, Hepatocellular Carcinoma, Hodgkin's Lymphoma, Malignant Pleural Mesothelioma, Melanoma, Melanoma - Metastatic, Non-Small... View more |
Prescription only
Prescribed for Hodgkin's Lymphoma, Melanoma, Melanoma - Metastatic. dacarbazine may also be used for purposes not listed in this medication guide. |
Related suggestions Hodgkin's Lymphoma
Popular comparisons
|
|||||||||||||||
| More about Bleomycin | More about Nivolumab | More about Dacarbazine | ||||||||||||||||
| Generic Status | ||||||||||||||||||
|
No lower-cost generic available |
||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Nivolumab has an average rating of 4.6 out of 10 from a total of 88 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 56% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
Commonly reported side effects include:
See also: bleomycin side effects in more detail. |
See also: nivolumab side effects in more detail. |
See also: dacarbazine side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all bleomycin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all dacarbazine prices |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Bleo 15k | Opdivo |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
30 hours |
640.8 hours |
5 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 227 drugs are known to interact with bleomycin:
|
A total of 15 drugs are known to interact with nivolumab:
|
A total of 232 drugs are known to interact with dacarbazine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
July 31, 1973 |
December 22, 2014 |
May 27, 1975 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.